Ryan Nelson
Editor-in-Chief, Medtech Insight, HBW Insight
Ryan has been covering the medical device and consumer health, wellness and beauty sectors since 2004, first as a reporter for Gray Sheet, where he covered beats including Capitol Hill, international and emerging technology, and then as managing editor of Rose Sheet. In his current role, he oversees and heads up strategy for their successor publications Medtech Insight and HBW Insight. He also manages and contributes regularly to HBW Insight’s Beauty channel with a focus on regulatory, policy and legal issues and has moderated related panels at industry events. Ryan has a growing role in developing podcasts, new features, “deep dive” article series, and infographics across teams and publications. Off the job, he enjoys spending time with his wife Katie, son Finn and daughter Maggie in Alexandria, VA, a DC suburb.
Latest From Ryan Nelson
‘Alexa, Give Me A Soulcare Tip’: E.l.f. Beauty Continues To Innovate New Marketing Angles
Recent announcements at e.l.f. Beauty include the launch of a Keys Soulcare theme on Amazon Alexa that allows users to hear inspiring words and receive beauty and wellness tips from Alicia Keys, plus the company’s introduction of real-world commerce on the Roblox gaming platform.
Sinaptica On Precision Neuromodulation To Combat Alzheimer’s: ‘No Drug Dares Go After Moderate Patients’
CEO Ken Mariash and scientific co-founder Giacomo Koch discuss plans for a Phase 3 trial in 2025 supporting Sinaptica’s combination of transcranial magnetic stimulation, electroencephalography and machine learning to slow Alzheimer’s progression. Potential synergies with anti-amyloid drugs, reflections on the US FDA’s TAP program, and insight into the company’s machine learning capabilities.
Syphilis OTC Test Developer NOWDiagnostics Raises $22.5M
The Series B funding round led by DigitalDx Ventures will support development and commercialization of more than 30 rapid diagnostic tests in NOWDx’s clinical research pipeline, including its First To Know Syphilis OTC test, currently under US FDA De Novo review, which provides at-home results in minutes.
Sinaptica’s Breakthrough Device Could Slow Brain Atrophy In Alzheimer’s Patients – Study
In a pilot study building on previously published Phase 2 trial results, Sinaptica’s precision therapy, combining repetitive transcranial magnetic stimulation with EEG monitoring and artificial intelligence, showed macro- and micro-structural grey matter preservation and increased functional connectivity in Alzheimer’s patients versus a sham treatment arm.
Syphilis OTC Test Developer NOWDiagnostics Raises $22.5M
The Series B funding round led by DigitalDx Ventures will support development and commercialization of more than 30 rapid diagnostic tests in NOWDx’s clinical research pipeline, including its First To Know Syphilis OTC test, currently under US FDA De Novo review, which provides at-home results in minutes.
Like ‘Natural’ And ‘Clean,’ Personal-Care Brands Must Be Prepared To Defend ‘Simple’ Claims
The National Advertising Division provides guidance to “minimalist” beauty and personal-care marketers with its review of “simple” claims on Native deodorant, body wash and other personal-care products.